LifeSciences Holdings Corporation, Plainsboro, NJ, has launched Integra Flowable Wound Matrix for the treatment of complex wounds. Integra has received 510(k) clearance from the US Food and Drug Administration to market Integra Flowable Wound Matrix in the United States. The advanced wound care device's design is based on Integra's proven collagen technology and provides an alternative to filling deep soft tissue or tunneling wounds in diabetic foot and venous leg ulcers, according to the manufacturer. When hydrated with saline, the matrix forms a gel that can be applied to difficult-to-access wound sites; and it provides a scaffold for cellular invasion and capillary growth. Integra Flowable Wound Matrix will be sold by Integra's Extremity Reconstruction sales organization.
In other company news, Integra LifeSciences Holdings Corporation has been selected by Medical Device & Diagnostic Industry magazine as "2007 Medical Device Manufacturer of the Year." Integra was selected for its innovative medical devices, commitment to research, market success, and its impressive quality and regulatory record. Since its inception in 1989, Integra has grown from a company with 1 product-an artificial skin, used in wound and burn care, called Integra Dermal Regeneration Template-to a company with thousands of medical devices and instruments.
DM Systems, Inc, Evanston, IL, offers a synopsis of an independent research project regarding heel pressure ulcers and heel pressure relief devices. Recently completed, the research involved surveying wound care nurses who encounter heel pressure ulcers on a regular basis. The purpose of the study was to explore trending in heel pressure ulcer prevalence as well as to determine what types of heel pressure relief devices wound care nurses prefer. The study began with an initial survey in 2004.
The results indicate that:
- Pressure relief boots and pillows are preferred over pressure relief mattresses and heel protectors by a wide margin.
- There is a direct correlation between working with a formal pressure ulcer protocol and choice of pressure relief device. Nurses whose workplace supports a formal protocol preferred boots over pillows a majority of the time.
- Many nurses indicated that they believe pressure relief boots are the best pressure relief devices for heel ulcer prevention and treatment. Of the nurses who stated that they believe pillows are preferable over pressure relief boots, only 15% indicated that pillows outperform boots in pressure relief prevention and treatment.
In addition to these results, the survey found that concern about heel pressure ulcers has increased in most facilities over the last 3 years. Correspondingly, most respondents indicated that pressure ulcer prevalence where they worked was not extremely high.
Driven by an aging population and continued advances in biotechnology, the worldwide surgical and trauma wound treatment market is expected to post a compound annual growth rate of 5.5% and grow to $7 billion by 2011, according to Wound Care Markets, Volume III: Surgical and Trauma Wounds, a new report by Kalorama Information, Rockville, MD. With more than 100,000 surgeries performed daily in the United States alone and millions performed annually worldwide, surgical and trauma wounds are the most common types of wounds addressed in the wound care area, and the aging world population has created increased demand for all types of surgical intervention, particularly cardiovascular, orthopedic, urological, and dermatological procedures.
Wound Care Markets, Volume III: Surgical and Trauma Wounds focuses on the world market for 6 product categories: wound closure, anti-infectives, surgical and trauma wound management, moist dressing, biological dressings, and miscellaneous treatments. The report analyzes products in development and on the market, leading competitors, and current issues and trends affecting the industry.